Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

US Patent 8535890 · Granted Sep 17, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2025
Combination immunotherapy compositions against cancer and methods2024
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutant2024
Yeast-brachyury immunotherapeutic compositions2024
Yeast-brachyury immunotherapeutic compositions2024
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2023
Combination immunotherapy compositions against cancer and methods2023
Combination immunotherapy compositions against cancer and methods2023
Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, an2022
Development of agonist epitopes of the human papillomavirus2022
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2021
Modified yeast-brachyury immunotherapeutic compositions2021